Get the Weekly Intelligence Brief — top committee picks every Sunday.

DAR vs UTI

Darling Ingredients vs Universal Technical Institute, Inc. — AI-powered side-by-side comparison
DAR
Darling Ingredients
66
Buy
VS
UTI
Universal Technical Institute, Inc.
53
Watch
MetricDARUTI
AI Score 66 53
Price $62.38 $25.56
P/E Ratio 16.54× 40.60×
ROE 1.3% 19.2%
Revenue Growth YoY
Gross Margin 25.0% 61.5%
Debt / Equity 0.80× 1.04×
Dividend Yield 0.0% 0.0%
RSI (14) 60.9 20.6
Beta 1.019 1.236
Expected Upside +5.1%

AI Committee View

Current Innellis committee reasoning for DAR versus UTI.
DAR leads by 13 points.

DAR scores 66/100 (Buy) versus UTI at 53/100 (Watch).

DAR Committee View
60% agreement
5 analysts

Positive signals support the current rating — eps growing 470.4% yoy. The committee sees sufficient evidence to maintain the constructive view.

Bull Case
  • Price-to-book of 1.3x is a discount to asset value — Value
  • EPS growing 470.4% YoY — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
  • ROE of only 4.7% -- cheap may mean cheap for a reason — Value
  • MACD histogram negative -- bearish momentum — Technical
UTI Committee View
67% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Technical Analyst remains cautious — rsi at 21 is in oversold territory (could mean either capitulation or a bounce setup). This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Low leverage (debt-to-equity 0.27) -- balance sheet can absorb a shock — Risk
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • P/E of 37.4 is moderate-to-rich — Value
  • Price-to-book of 5.4x prices in significant intangible value — Value
  • EPS declining -25.9% YoY despite any revenue growth — Growth
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
DAR Full Analysis UTI Full Analysis